Concentration risk percentage
Breakdown
Segments
Naloxone productsView metric
Other Commercial ProductsView metric
Anthrax MCMView metric
Smallpox MCMView metric
Other ProductsView metric
| Segment | FY'23 | FY'24 | FY'25 |
|---|---|---|---|
| Smallpox MCM | 18% | 31% | 39% |
| Naloxone products | — | — | 33% |
| Anthrax MCM | 20% | 15% | 17% |
| Other Products | 10% | 10% | 11% |
| Other Commercial Products | 1% | 0% | 0% |
| Total | — | — | — |
All segment values are derived from annual filings.